DeFinium Therapeutics Inc (DFTX)
DeFinium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -10,699 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,217 | N/A | N/A |
| Other Working Capital | 1,927 | N/A | N/A |
| Other Operating Activity | 4,356 | 0 | 0 |
| Operating Cash Flow | $-3,199 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 9,902 | N/A | N/A |
| Financing Cash Flow | $9,902 | $N/A | $N/A |
| End Cash Position | 6,703 | N/A | N/A |
| Net Cash Flow | $6,703 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -3,199 | N/A | N/A |
| Free Cash Flow | -3,199 | 0 | 0 |